CSIMarket
 


Array Biopharma Inc  (ARRY)
Other Ticker:  
 
 

ARRY's Net Income Growth by Quarter and Year

Array Biopharma Inc's Net Income results by quarter and year




ARRY Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter June - 92.55 -29.59 -24.97
III Quarter March -37.49 -22.85 -35.32 -22.68
II Quarter December -11.36 -34.05 -23.30 -24.16
I Quarter September -24.81 -37.99 -28.61 -20.99
FY   -73.66 -2.34 -116.82 -92.80



ARRY Net Income third quarter 2019 Y/Y Growth Comment
Array Biopharma Inc in the third quarter recorded net loss of $ -37.49 millions.

According to the results reported in the third quarter, Array Biopharma Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Array Biopharma Inc' s Net Income no change of % ranks overall at the positon no. in the third quarter.




ARRY Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Array Biopharma Inc's third quarter 2019 Net Income $ -37.49 millions ARRY's Income Statement
Array Biopharma Inc's third quarter 2018 Net Income $ -22.85 millions Quarterly ARRY's Income Statement
New: More ARRY's historic Net Income Growth >>


ARRY Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Array Biopharma Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ARRY's III. Quarter Q/Q Net Income Comment
Current results of -37.49 millions by Array Biopharma Inc appear even worse considering the -11.36 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Array Biopharma Inc achieved highest sequential Net Income growth. While Array Biopharma Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ARRY's III. Quarter Q/Q Net Income Comment
Recent accomplishment of -37.49 millions by Array Biopharma Inc look even more unfavourable considering the net loss -11.36 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Array Biopharma Inc achieved highest sequential Net Income growth. While Array Biopharma Inc's Net Income growth quarter on quarter, overall rank is .


Array Biopharma Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
Cumulative Net Income 12 Months Ending $ 18.89 $ 33.53 $ 10.84 $ -2.35 $ -124.49
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) -43.67 % 209.38 % - - -
Seq. Net Income Growth (TTM) Overall Ranking # 1727 # 0 # 0 # 0 # 0




Cumulative Net Income growth Comment
In the Mar 31 2019 period, Array Biopharma Inc had cumulative twelve months Net Income of $ 19 millions compare to net loss of $ -124 millions a year ago.

Array Biopharma Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
209.38 %
10.97 %
-97.36 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 111
S&P 500 # 1727
Cumulative Net Income growth Comment
In the Mar 31 2019 period, Array Biopharma Inc had cumulative twelve months Net Income of $ 19 millions compare to net loss of $ -124 millions a year ago.

Array Biopharma Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
209.38 %
10.97 %
-97.36 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 111
S&P 500 # 1727




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ARRY's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ARRY's Competitors
Net Income Growth for Array Biopharma Inc's Suppliers
Net Income Growth for ARRY's Customers

You may also want to know
ARRY's Annual Growth Rates ARRY's Profitability Ratios ARRY's Asset Turnover Ratio ARRY's Dividend Growth
ARRY's Roe ARRY's Valuation Ratios ARRY's Financial Strength Ratios ARRY's Dividend Payout Ratio
ARRY's Roa ARRY's Inventory Turnover Ratio ARRY's Growth Rates ARRY's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2019
Integrated Biopharma Inc  108.35 %$ 108.352 millions
Abiomed Inc  100.72 %$ 100.725 millions
Penumbra Inc  90.38 %$ 90.384 millions
Jazz Pharmaceuticals Plc  85.26 %$ 85.256 millions
Cardiovascular Systems, Inc.  84.11 %$ 84.110 millions
Celgene Corp  82.62 %$ 82.624 millions
Neurometrix, Inc.  75.82 %$ 75.820 millions
Haemonetics Corp  75.38 %$ 75.379 millions
Hill-rom Holdings, Inc.  73.68 %$ 73.684 millions
Catalent, Inc.  66.84 %$ 66.842 millions
Abbott Laboratories  60.77 %$ 60.766 millions
Pro Dex Inc  52.50 %$ 52.500 millions
Tenax Therapeutics, Inc.  37.07 %$ 37.072 millions
Meridian Bioscience Inc  34.15 %$ 34.153 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TKKS's Profile

Stock Price

TKKS's Financials

Business Description

Fundamentals

Charts & Quotes

TKKS's News

Suppliers

TKKS's Competitors

Customers & Markets

Economic Indicators

TKKS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071